MedTrace Logo

Uterine Filling Pressure in Hysteroscopy

NCT04550429 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2026-04-30

Study results available
· View outcomes & findings →

Summary

The aim of the study is to compare the outcomes of patients undergoing hysteroscopy with a MyoSure device with a pressure of 60 mmHg to those using the standard of 80 mmHg.

Conditions

  • Fibroids

Interventions

DEVICE

MyoSure Hysteroscopic Morcellator Device

This device is normally used for this procedure, but the investigators included it as an intervention because the pressure will be lowered for one arm of the study (treatment) and the pressure in the other arm will be remain unchanged (control) as the standard of care.

Sponsors & Collaborators

Principal Investigators

  • Magdy P Milad, MD, MM · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-21
Primary Completion
2023-09-11
Completion
2023-09-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04550429 on ClinicalTrials.gov